Saxagliptin + metformin

Details

Files
Generic Name:
Saxagliptin + metformin
Project Status:
Withdrawn
Therapeutic Area:
Diabetes Mellitus, Type 2
Manufacturer:
Bristol-Myers Squibb / AstraZeneca Canada Inc.
Call for patient/clinician input open:
Brand Name:
Komboglyze
Project Line:
Reimbursement Review
Project Number:
SR0336-000
Call for patient/clinician input closed:
Performance Metric:
N/A — Predated performance metrics
Submission Type:
Initial
Indications:
Diabetes Mellitus, Type 2